BEVERLEY POWELL: Open Payments
NPI 1285176933 · SUNRISE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 26 payments from 7 companies in 2025. Trend: 2023 $873 · 2024 $500 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $157 |
| E.R. Squibb & Sons, L.L.C. | 2 | $142 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $48 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
Products named: Auvelity, CAPLYTA, COBENFY, INGREZZA, AUSTEDO XR, Qelbree, SPRAVATO.
Industry payments across FL — which companies pay providers there.
